Insulin-Like Growth Factor Receptor-1 as an Anti-Cancer Target: Blocking Transformation and Inducing Apoptosis
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
191-207
Author(s):
Yuli Wang and Yi Sun
Cancer-Targeted Polymeric Drugs
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
209-226
Author(s):
Y. Luo and G. D. Prestwich
Cancer Therapy with ß-Lapachone
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
227-242
Author(s):
Arthur B. Pardee, You Zhi Li and Chiang J. Li
Pharmacogenomics Opportunities in Nuclear Receptor Targeted Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
243-256
Author(s):
M. Schapira
Examining the Relationship between Cancer Invasion / Metastasis and Drug Resistance
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
257-277
Author(s):
Y. Liang, S. McDonnell and M. Clynes
Engineering Antibodies for Therapy
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
237-256
Author(s):
Leonard G. Presta
Modulating Poly (ADP-Ribose) Polymerase Activity: Potential for the Prevention and Therapy of Pathogenic Situations Involving DNA Damage and Oxidative Stress
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
275-283
Author(s):
Patrice Decker and Sylviane Muller
Acridine Derivatives as Chemotherapeutic Agents
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
1655-1665
Author(s):
William A. Denny
4-Anilino-3-quinolinecarbonitriles: An Emerging Class of Kinase Inhibitors
Journal:
Current Topics in Medicinal Chemistry
Volume:
2
Page:
1051-1063
Author(s):
Diane H. Boschelli
Telomerase Inhibitors as Anticancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
567-575
Author(s):
Masaharu Akiyama, Teru Hideshima, Nikhil C. Munshi and Kenneth C. Anderson